Myoblast therapy for stress urinary incontinence and bladder dysfunction
- Cite this article as:
- Yokoyama, T., Huard, J. & Chancellor, M. World J Urol (2000) 18: 56. doi:10.1007/s003450050010
- 70 Downloads
The field of tissue engineering and gene therapy has an exciting and promising future. During the past few years we have begun a comprehensive effort to investigate the use of myoblasts to improve and expand the treatment of stress urinary incontinence and bladder dysfunction. Moreover, we can expect the application of myoblast-mediated ex vivo gene transfer in the field of urology. In this paper we discuss the compositions of and methods involving the use of myogenic or muscle-derived cells for tissue engineering and cell-mediated gene therapy.